Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
URGN holding history
UroGen Pharma Ltd. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
URGN overviewAll 13F holders of URGNFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −24,839−100.0% | Sold out | Holders |
| Q2 2025 | 24,839 | $340.3K | <0.1% | −7,923−24.2% | Reduced | Holders |
| Q1 2025 | 32,762 | $362.3K | <0.1% | −1,359−4.0% | Reduced | Holders |
| Q4 2024 | 34,121 | $363.4K | <0.1% | −28−0.1% | Reduced | Holders |
| Q3 2024 | 34,149 | $433.7K | <0.1% | +34,149 | New | Holders |